Quinolines useful in treating cardiovascular disease
申请人:Collini D. Michael
公开号:US20050131014A1
公开(公告)日:2005-06-16
This invention provides compounds of formula I
that are useful in the treatment or inhibition of LXR mediated diseases.
本发明提供了式I化合物的用途,它们在治疗或抑制LXR介导的疾病中是有用的。
5-Lipoxygenase modulators
申请人:Nambi Ponnal
公开号:US20070093524A1
公开(公告)日:2007-04-26
The present invention provides the use of Liver X Receptor (LXR) modulators that have been identified to downregulate 5-lipoxygenase gene expression in order to treat various diseases and disorders that involve the function of the 5-LO protein in intracellular signaling (or other cellular processes) or the function of protein products downstream of 5-LO in intracellular signaling (i.e., leukotrienes).